Literature DB >> 17330195

Imaging in sarcoidosis.

Hilario Nunes1, Pierre-Yves Brillet, Dominique Valeyre, Michel W Brauner, Athol U Wells.   

Abstract

Sarcoidosis is a multisystemic granulomatous disease of unknown etiology that may involve virtually any organ. Pulmonary involvement predominates, but sarcoidosis can involve multiple organs, with or without concomitant lung involvement. Aberrations on chest radiographs are present in more than 90% of patients with sarcoidosis. Bilateral hilar lymphadenopathy, with or without lung parenchymal infiltrates, is typical but a wide range of chest radiographic patterns may be observed. This article discusses the characteristic chest radiographic features of sarcoidosis and the prognostic value of the radiographic staging classification as espoused by Scadding more than 4 decades ago. Thin-section high-resolution computed tomographic (HRCT) scans more clearly elucidate the intrathoracic lesions observed in sarcoidosis and may discriminate active inflammation from end-stage fibrosis. Although HRCT is not necessary to manage all cases of sarcoidosis, HRCT may be invaluable in SELECTED patients with stage II or III sarcoidosis to discriminate alveolitis (which may be amenable to therapy) from fibrosis. Additionally, radionuclide techniques may have a role in extrapulmonary sarcoidosis (particularly when central nervous system or cardiac involvement is suspected). We review the salient features and role of magnetic resonance imaging and diverse radionuclide techniques to diagnose or follow selected cases of extrapulmonary sarcoidosis.

Entities:  

Mesh:

Year:  2007        PMID: 17330195     DOI: 10.1055/s-2007-970336

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  25 in total

Review 1.  Imaging of Sarcoidosis.

Authors:  Mario Silva; Hilario Nunes; Dominique Valeyre; Nicola Sverzellati
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 2.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

Review 3.  [Sarcoidosis].

Authors:  A Prasse; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

4.  Cardiac sarcoidosis: a challenge to measure disease activity.

Authors:  Ruth G M Keijsers; Fred J Verzijlbergen; Benno J W M Rensing; Jan C Grutters
Journal:  J Nucl Cardiol       Date:  2008-04-08       Impact factor: 5.952

5.  New-Onset Sarcoidosis After Remission of Cushing's Syndrome.

Authors:  Alev Selek; Serap Barış; Berrin Çetinaslan; Zeynep Cantürk; İlhan Tarkun; Zeynep Akyay
Journal:  Turk Thorac J       Date:  2015-06-12

6.  Volumetric FDG PET analysis of global lung inflammation: new tool for precision medicine in pulmonary sarcoidosis?

Authors:  Human Adams; Rob van Rooij; Coline H M van Moorsel; Marcela Spee-Dropkova; Jan C Grutters; Ruth G Keijsers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 7.  Lung transplantation for pulmonary sarcoidosis.

Authors:  Keith C Meyer
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

8.  Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study.

Authors:  J Choi; L A Hoffman; J M Sethi; T G Zullo; K F Gibson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

Review 9.  The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis.

Authors:  Antje Prasse
Journal:  Dtsch Arztebl Int       Date:  2016-08-22       Impact factor: 5.594

10.  Central skeletal sarcoidosis mimicking metastatic disease.

Authors:  Danit Talmi; Stacy Smith; Michael E Mulligan
Journal:  Skeletal Radiol       Date:  2008-04-10       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.